Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2026

Description

Advanced therapeutic pharmaceutical outsourcing involves delegating specialized pharmaceutical services associated with advanced therapeutic products to external providers. These products typically include innovative therapies such as cell and gene therapies, personalized medicines, biologics, and other novel treatments. Such outsourcing is utilized to access specialized expertise and capabilities required for the development, testing, and manufacturing of advanced therapeutic products.

The primary services in advanced therapeutics pharmaceutical outsourcing include contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs). Outsourcing services provided to CROs may encompass a variety of specialized solutions that support the development and commercialization of advanced therapeutic products. These services are applied across indications such as oncology, neurology, cardiology, infectious diseases, and others, and involve outsourcing cell therapy, gene therapy, and RNA-based therapies for preclinical services, clinical services, as well as commercial manufacturing and packaging applications.

Tariffs have influenced the advanced therapeutics pharmaceutical outsourcing market by increasing the cost of importing critical raw materials such as viral vectors, single-use bioprocessing equipment, and analytical instruments used in cell and gene therapy development. These impacts are most pronounced across cdmo manufacturing services and analytical testing segments, particularly in North America and Europe, which rely heavily on cross-border supply chains. Asia-Pacific outsourcing hubs are also affected due to tariffs on specialized equipment sourced from the US and EU. However, tariffs have encouraged regional capacity expansion, local sourcing strategies, and long-term investments in domestic advanced therapy manufacturing infrastructure.

The advanced therapeutics pharmaceutical outsourcing market research report is one of a series of new reports from The Business Research Company that provides advanced therapeutics pharmaceutical outsourcing market statistics, including advanced therapeutics pharmaceutical outsourcing industry global market size, regional shares, competitors with a advanced therapeutics pharmaceutical outsourcing market share, detailed advanced therapeutics pharmaceutical outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the advanced therapeutics pharmaceutical outsourcing industry. This advanced therapeutics pharmaceutical outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The advanced therapeutics pharmaceutical outsourcing market size has grown steadily in recent years. It will grow from $8.41 billion in 2025 to $8.82 billion in 2026 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to rising biologics pipeline, high cost of in-house manufacturing, increasing prevalence of oncology and rare diseases, lack of internal expertise in advanced therapies, globalization of clinical trials.

The advanced therapeutics pharmaceutical outsourcing market size is expected to see strong growth in the next few years. It will grow to $10.73 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to growth in personalized medicine adoption, expansion of commercial-scale cell and gene therapies, increasing regulatory complexity, surge in biotech start-up funding, demand for faster time-to-market. Major trends in the forecast period include increasing outsourcing of cell and gene therapy manufacturing, rising demand for end-to-end cdmo services, expansion of specialized viral vector production capabilities, growing focus on regulatory and quality compliance support, accelerated clinical trial outsourcing for rare and complex indications.

The growing adoption of cell and gene therapies is expected to drive the expansion of the advanced therapeutics pharmaceutical outsourcing market in the coming years. Cell and gene therapies are cutting-edge treatments that utilize living cells or genetic material to treat or potentially cure diseases. Advanced therapeutics pharmaceutical outsourcing supports these therapies by providing access to providers with proven expertise and experienced personnel, helping companies save time and resources in building their in-house teams. For instance, in March 2024, IQVIA Holdings Inc., a US-based provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare sectors, reported that global spending on cell and gene therapies reached $5.9 billion in 2023, representing a 38% increase from 2022. Therefore, the rising adoption of cell and gene therapies is fueling growth in the advanced therapeutics pharmaceutical outsourcing market.

Major companies in the advanced therapeutics pharmaceutical outsourcing market are focusing on strategic partnerships to deliver dependable services to clients. A strategic partnership is a collaborative arrangement between two or more organizations formed to achieve mutually beneficial objectives that each partner could not accomplish alone. For instance, in January 2023, Lonza, a Switzerland-based manufacturer serving the pharmaceutical, biotechnology, and nutrition sectors, partnered with Context Therapeutics Inc., a US-based biopharmaceutical company developing medicines for solid tumors. Under the partnership, Lonza provides manufacturability assessment, gene and cell line construction, and process development for both drug substances and drug products.

In December 2023, Ajinomoto Co., Inc., a Japan-based provider of amino acids and biomanufacturing solutions, completed the acquisition of Forge Biologics Inc. for an undisclosed amount. Through this acquisition, Ajinomoto aims to strengthen its position in the gene therapy manufacturing market by expanding viral vector production capabilities, enhancing its CDMO service offerings, and accelerating innovation in advanced gene therapy development. Forge Biologics Inc. is a US-based gene therapy-focused CDMO specializing in adeno-associated virus manufacturing and comprehensive end-to-end development services.

Major companies operating in the advanced therapeutics pharmaceutical outsourcing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, AGC Biologics, Evotec SE, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cytovance Biologics

North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2025. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the advanced therapeutics pharmaceutical outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The advanced therapeutics pharmaceutical outsourcing market includes revenues earned by entities by providing services such as research and development support, process development and manufacturing, comprehensive analytical testing and characterization, regulatory support, clinical manufacturing, commercial manufacturing, implementation of quality systems, consulting and strategic services. The market value includes the value of related goods sold by the service provider or included within the service offering.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Advanced Therapeutics Pharmaceutical Outsourcing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses advanced therapeutics pharmaceutical outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for advanced therapeutics pharmaceutical outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The advanced therapeutics pharmaceutical outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Service Type: Contract Research Organizations (CROs); Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology; Neurology; Other Indications
3) By Therapy: Cell Therapy; Gene Therapy; RNA-based Therapies
4) By Application: Preclinical Services; Clinical Services; Commercial Manufacturing And Packaging
Subsegments:
1) By Contract Research Organizations (CROs): Preclinical Research Services; Clinical Trial Management Services; Regulatory Affairs Services; Data Management And Biostatistics
2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services; Formulation Development; Analytical Testing Services; Commercial Manufacturing Services
Companies Mentioned: Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; IQVIA; ICON plc; SGS SA; Lonza Group; Parexel International Corporation; WuXi AppTec; Syneos Health; Catalent Inc.; Charles River Laboratories International; Recipharm AB; Samsung Biologics; Vetter Pharma International GmbH; Medpace Holdings Inc.; Fujifilm Diosynth Biotechnologies; AGC Biologics; Evotec SE; Piramal Pharma Solutions; Corden Pharma International LLC; Novotech Pty Ltd.; Cytovance Biologics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH3MATPO01_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Advanced Therapeutics Pharmaceutical Outsourcing Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Advanced Therapeutics Pharmaceutical Outsourcing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Artificial Intelligence & Autonomous Intelligence
- 4.1.2 Biotechnology, Genomics & Precision Medicine
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Increasing Outsourcing Of Cell And Gene Therapy Manufacturing
- 4.2.2 Rising Demand For End-To-End Cdmo Services
- 4.2.3 Expansion Of Specialized Viral Vector Production Capabilities
- 4.2.4 Growing Focus On Regulatory And Quality Compliance Support
- 4.2.5 Accelerated Clinical Trial Outsourcing For Rare And Complex Indications

5. Advanced Therapeutics Pharmaceutical Outsourcing Market Analysis Of End Use Industries

5.1 Biopharmaceutical Companies
5.2 Biotechnology Companies
5.3 Cell And Gene Therapy Developers
5.4 Research Institutes And Academic Centers
5.5 Contract Manufacturing Partners

6. Advanced Therapeutics Pharmaceutical Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Advanced Therapeutics Pharmaceutical Outsourcing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Advanced Therapeutics Pharmaceutical Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size, Comparisons And Growth Rate Analysis
7.3. Global Advanced Therapeutics Pharmaceutical Outsourcing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Advanced Therapeutics Pharmaceutical Outsourcing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Advanced Therapeutics Pharmaceutical Outsourcing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Advanced Therapeutics Pharmaceutical Outsourcing Market Segmentation

9.1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
9.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oncology, Neurology, Other Indications
9.3. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cell Therapy, Gene Therapy, RNA-based Therapies
9.4. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging
9.5. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Sub-Segmentation Of Contract Research Organizations (CROs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Preclinical Research Services, Clinical Trial Management Services, Regulatory Affairs Services, Data Management And Biostatistics
9.6. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Sub-Segmentation Of Contract Development And Manufacturing Organizations (CDMOs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Drug Development Services, Formulation Development, Analytical Testing Services, Commercial Manufacturing Services

10. Advanced Therapeutics Pharmaceutical Outsourcing Market Regional And Country Analysis

10.1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market

11.1. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Advanced Therapeutics Pharmaceutical Outsourcing Market

12.1. China Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Advanced Therapeutics Pharmaceutical Outsourcing Market

13.1. India Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market

14.1. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Advanced Therapeutics Pharmaceutical Outsourcing Market

15.1. Australia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Advanced Therapeutics Pharmaceutical Outsourcing Market

16.1. Indonesia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market

17.1. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Advanced Therapeutics Pharmaceutical Outsourcing Market

18.1. Taiwan Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Advanced Therapeutics Pharmaceutical Outsourcing Market

19.1. South East Asia Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Advanced Therapeutics Pharmaceutical Outsourcing Market

20.1. Western Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Advanced Therapeutics Pharmaceutical Outsourcing Market

21.1. UK Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market

22.1. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Advanced Therapeutics Pharmaceutical Outsourcing Market

23.1. France Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market

24.1. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market

25.1. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Advanced Therapeutics Pharmaceutical Outsourcing Market

26.1. Eastern Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market

27.1. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Advanced Therapeutics Pharmaceutical Outsourcing Market

28.1. North America Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Advanced Therapeutics Pharmaceutical Outsourcing Market

29.1. USA Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market

30.1. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Advanced Therapeutics Pharmaceutical Outsourcing Market

31.1. South America Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market

32.1. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market

33.1. Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Advanced Therapeutics Pharmaceutical Outsourcing Market

34.1. Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Segmentation By Indication, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Advanced Therapeutics Pharmaceutical Outsourcing Market Regulatory and Investment Landscape

36. Advanced Therapeutics Pharmaceutical Outsourcing Market Competitive Landscape And Company Profiles

36.1. Advanced Therapeutics Pharmaceutical Outsourcing Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Advanced Therapeutics Pharmaceutical Outsourcing Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Advanced Therapeutics Pharmaceutical Outsourcing Market Company Profiles
- 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. IQVIA Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. ICON plc Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. SGS SA Overview, Products and Services, Strategy and Financial Analysis

37. Advanced Therapeutics Pharmaceutical Outsourcing Market Other Major And Innovative Companies

Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, AGC Biologics, Evotec SE, Piramal Pharma Solutions, Corden Pharma International LLC

38. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Advanced Therapeutics Pharmaceutical Outsourcing Market

40. Advanced Therapeutics Pharmaceutical Outsourcing Market High Potential Countries, Segments and Strategies

40.1 Advanced Therapeutics Pharmaceutical Outsourcing Market In 2030 - Countries Offering Most New Opportunities
40.2 Advanced Therapeutics Pharmaceutical Outsourcing Market In 2030 - Segments Offering Most New Opportunities
40.3 Advanced Therapeutics Pharmaceutical Outsourcing Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer